Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Interactive Model
|
This model contains a ten year commercial forecast of hepatitis B drug sales by country, class, molecule and brand across the US, Japan, France, Germany, Italy, Spain, UK and Turkey.
Published By Datamonitor
|
02 Aug 2010 |
$15200
|
Interactive Model
|
Provides indication- and country-specific 10-year forecasts of key marketed, generic, and pipeline fibromyalgia drugs to 2018.
Published By Datamonitor
|
03 Jun 2009 |
$15200
|
Interactive Model
|
Excel deliverable containing data on marketed and pipeline biosimilars in the EU
Published By Datamonitor
|
10 Aug 2012 |
$15200
|
Interactive Model
|
Assessment of the future depression drug market using patient-based forecasting methodology.
Published By Datamonitor
|
19 Jan 2012 |
$11400
|
Interactive Model
|
This interactive model includes 2011-20 forecast sales for chronic obstructive pulmonary disease (COPD) in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK).
Published By Datamonitor
|
29 Nov 2011 |
$11400
|
Interactive Model
|
Marketing synopsis: This interactive model includes 2011-20 forecast sales for chronic obstructive pulmonary disease (COPD) in China.
Published By Datamonitor
|
14 Dec 2011 |
$11400
|
Interactive Model
|
In-depth review of the cardiovascular and metabolic markets, including analysis and comparison of key sales trends in the therapy areas of diabetes, dyslipidemia, hypertension and thrombosis over the forecast (2010–19) period.
Published By Datamonitor
|
08 Feb 2011 |
$15200
|
Interactive Model
|
Provides analysis of key events and their impact on the ADHD market since 2008. Includes an event-based and country-specific 10 year forecast of key marketed, generic, and pipeline products to 2018 in the seven major markets.
Published By Datamonitor
|
03 Jul 2009 |
$15200
|
Interactive Model
|
Asthma and COPD market forecast for the seven major markets, incorporating the latest data from the European Respiratory Society 2010 Congress. Recent advances and setbacks of marketed/pipeline products and generics companies' actions are covered.
Published By Datamonitor
|
29 Sep 2010 |
$15200
|
Interactive Model
|
In-depth overview and 10 year outlook for currently marketed and pipeline asthma/COPD products in Australia, examining both clinical and commercial factors driving product differentiation and uptake.
Published By Datamonitor
|
20 May 2010 |
$5700
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.